Andrea L Rosso1, Nicolaas I Bohnen2, Lenore J Launer2, Howard J Aizenstein2, Kristine Yaffe2, Caterina Rosano2. 1. From the Department of Epidemiology, Graduate School of Public Health (A.L.R., C.R.), and Department of Psychiatry (H.J.A.), University of Pittsburgh, PA; Departments of Radiology and Neurology (N.I.B.), University of Michigan, Ann Arbor; Laboratory of Epidemiology and Population Sciences (L.J.L.), National Institute on Aging, Baltimore, MD; and Departments of Psychiatry, Neurology, and Epidemiology & Biostatistics (K.Y.), University of California, San Francisco. alr143@pitt.edu. 2. From the Department of Epidemiology, Graduate School of Public Health (A.L.R., C.R.), and Department of Psychiatry (H.J.A.), University of Pittsburgh, PA; Departments of Radiology and Neurology (N.I.B.), University of Michigan, Ann Arbor; Laboratory of Epidemiology and Population Sciences (L.J.L.), National Institute on Aging, Baltimore, MD; and Departments of Psychiatry, Neurology, and Epidemiology & Biostatistics (K.Y.), University of California, San Francisco.
Abstract
OBJECTIVE: Mild parkinsonian signs (MPS) are an underappreciated neurologic condition in older adults; we assessed associations of MPS with measures of dopaminergic (catechol-O-methyltransferase [COMT] genotype, an indicator of synaptic dopamine levels) and vascular (white matter hyperintensities [WMH], an indicator of cerebral small vessel disease) factors. METHODS: In a cohort of older adults (mean age 82.6 years [SD 2.6]; 58.0% female; 38.8% black), we assessed cross-sectional associations of WMH volume and COMT Val158Met (rs4680) genotype (n = 35 Met/Met, n = 180 Val carriers) with MPS by regression models adjusted for demographic and health characteristics. Interactions between WMH and COMT were assessed and analyses were repeated stratified by COMT genotype (Met/Met related to higher synaptic dopamine vs Val carriers related to lower synaptic dopamine). RESULTS: MPS was present in 42.3% of our sample. WMH (odds ratio [OR] 1.16, confidence interval [CI] 1.05-1.27) but not COMT (Met/Met compared to Val carrier: OR 0.62, CI 0.27-1.42) was related to MPS. There was a significant interaction between WMH and COMT (p = 0.03). Stratified analyses reveled a strong association between WMH and MPS among COMT Val carriers (OR 1.23, CI 1.09-1.38), but not for Met/Met (OR 0.68, CI 0.45-1.02), independent of covariates. CONCLUSIONS: WMH had a direct relation with MPS. In contrast, COMT was not associated with MPS, but it did modify the effect of WMH on MPS. The dopaminergic system may provide compensation for the effects of WMH on MPS. These findings suggest that MPS has a vascular rather than dopaminergic origin in older adults, but both factors are important in MPS manifestation.
OBJECTIVE: Mild parkinsonian signs (MPS) are an underappreciated neurologic condition in older adults; we assessed associations of MPS with measures of dopaminergic (catechol-O-methyltransferase [COMT] genotype, an indicator of synaptic dopamine levels) and vascular (white matter hyperintensities [WMH], an indicator of cerebral small vessel disease) factors. METHODS: In a cohort of older adults (mean age 82.6 years [SD 2.6]; 58.0% female; 38.8% black), we assessed cross-sectional associations of WMH volume and COMT Val158Met (rs4680) genotype (n = 35 Met/Met, n = 180 Val carriers) with MPS by regression models adjusted for demographic and health characteristics. Interactions between WMH and COMT were assessed and analyses were repeated stratified by COMT genotype (Met/Met related to higher synaptic dopamine vs Val carriers related to lower synaptic dopamine). RESULTS: MPS was present in 42.3% of our sample. WMH (odds ratio [OR] 1.16, confidence interval [CI] 1.05-1.27) but not COMT (Met/Met compared to Val carrier: OR 0.62, CI 0.27-1.42) was related to MPS. There was a significant interaction between WMH and COMT (p = 0.03). Stratified analyses reveled a strong association between WMH and MPS among COMT Val carriers (OR 1.23, CI 1.09-1.38), but not for Met/Met (OR 0.68, CI 0.45-1.02), independent of covariates. CONCLUSIONS: WMH had a direct relation with MPS. In contrast, COMT was not associated with MPS, but it did modify the effect of WMH on MPS. The dopaminergic system may provide compensation for the effects of WMH on MPS. These findings suggest that MPS has a vascular rather than dopaminergic origin in older adults, but both factors are important in MPS manifestation.
Authors: Susumu Mori; Kenichi Oishi; Hangyi Jiang; Li Jiang; Xin Li; Kazi Akhter; Kegang Hua; Andreia V Faria; Asif Mahmood; Roger Woods; Arthur W Toga; G Bruce Pike; Pedro Rosa Neto; Alan Evans; Jiangyang Zhang; Hao Huang; Michael I Miller; Peter van Zijl; John Mazziotta Journal: Neuroimage Date: 2008-01-03 Impact factor: 6.556
Authors: Karlijn F de Laat; Anil M Tuladhar; Anouk G W van Norden; David G Norris; Marcel P Zwiers; Frank-Erik de Leeuw Journal: Brain Date: 2010-12-14 Impact factor: 13.501
Authors: Andrea L Metti; Caterina Rosano; Robert Boudreau; Robyn Massa; Kristine Yaffe; Suzanne Satterfield; Tamara Harris; Andrea L Rosso Journal: J Am Geriatr Soc Date: 2017-06-22 Impact factor: 5.562
Authors: G Abellan van Kan; Y Rolland; S Andrieu; J Bauer; O Beauchet; M Bonnefoy; M Cesari; L M Donini; S Gillette Guyonnet; M Inzitari; F Nourhashemi; G Onder; P Ritz; A Salva; M Visser; B Vellas Journal: J Nutr Health Aging Date: 2009-12 Impact factor: 4.075
Authors: Karlijn F de Laat; Anouk G W van Norden; Rob A R Gons; Inge W M van Uden; Marcel P Zwiers; Bastiaan R Bloem; Ewoud J van Dijk; Frank-Erik de Leeuw Journal: Stroke Date: 2012-08-02 Impact factor: 7.914
Authors: Caterina Rosano; Andrea L Metti; Andrea L Rosso; Stephanie Studenski; Nicolaas I Bohnen Journal: J Gerontol A Biol Sci Med Sci Date: 2020-03-09 Impact factor: 6.053
Authors: Cameron Miller-Patterson; Jennifer Han; Kristine Yaffe; Andrea L Rosso; Lenore J Launer; Stephen B Kritchevsky; Robert M Boudreau; Caterina Rosano Journal: Parkinsonism Relat Disord Date: 2020-05-22 Impact factor: 4.891
Authors: Zhuang Wu; Hang Xu; Sha Zhu; Ruxin Gu; Min Zhong; Xu Jiang; Bo Shen; Jun Zhu; Yang Pan; Jingde Dong; Jun Yan; Wenbin Zhang; Li Zhang Journal: Risk Manag Healthc Policy Date: 2021-03-15
Authors: Shahram Oveisgharan; Lei Yu; Lisa L Barnes; Sonal Agrawal; Julie A Schneider; David A Bennett; Aron S Buchman Journal: Neurology Date: 2022-03-23 Impact factor: 11.800
Authors: Qu Tian; Rebecca Ehrenkranz; Andrea L Rosso; Nancy W Glynn; Lana M Chahine; James Hengenius; Xiaonan Zhu; Caterina Rosano Journal: J Gerontol A Biol Sci Med Sci Date: 2022-04-01 Impact factor: 6.591